Cargando…
In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine
[Image: see text] Actively targeted theranostic nanomedicine may be the key for future personalized cancer management. Although numerous types of theranostic nanoparticles have been developed in the past decade for cancer treatment, challenges still exist in the engineering of biocompatible theranos...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Chemical Society
2015
|
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414921/ https://www.ncbi.nlm.nih.gov/pubmed/25843647 http://dx.doi.org/10.1021/nn507241v |